


Another NameVolibris,LuciAmb,安立生坦
Indications
It is indicated for the treatment of adult patients with pulmonary arterial hypertension (PAH, WHO Group 1), which can improve exercise capacity, delay clinical deterioration, or be used in c
Reg No.03 L 1315/25
Inspection No.
WhatsApp: